---

$16.37

+0.4550 ( +2.86% ) 272.7K

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Open	$16.37
Previous Close	$15.91
Volume	272.7K
Market Cap	$5.67B
Day Range	$14.92 - $16.69
52 Week Range	$12.02 - $18.92
Shares Outstanding	356.54M
Change %	+2.86%
Net Change	▲ 0.4550
Insider Ownership	N/A
Exchange	NYSE
Sector	Industrials
Industry	OPHTHALMIC GOODS
IPO Year	2022
Country	United States
Underwriter	IPO Intelligence Only

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2025-05-27	Buy	22000.00	SAUNDERS BRENT L
2025-05-06	Buy	1695.00	VON ESCHENBACH ANDREW C.